Key Considerations for Selecting a Genomic Decision Support Platform for Implementing Pharmacogenomics-Reference-Cited by-同舟云学术

Key Considerations for Selecting a Genomic Decision Support Platform for Implementing Pharmacogenomics

Published:2021-07-13 Issue:3 Volume:110 Page:555-558
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharmacol Ther

Author:

Cook Kelsey J.¹²,Duong Benjamin Q.³,Seligson Nathan D.¹²,Arn Pamela²,Funanage Vicky L.³,Gripp Karen W.³⁴,Kirwin Susan M.³,Lawless Stephen T.³⁴,Lee Mary M.³⁴,Robbins Katherine M.³,West David³,Blake Kathryn V.²

Affiliation:

1. Department of Pharmacotherapy and Translational Research The University of Florida College of Pharmacy Jacksonville Florida USA

2. Precision Medicine Program Nemours Children’s Health Jacksonville Florida USA

3. Precision Medicine Program Nemours Children’s Health Wilmington Delaware USA

4. Sidney Kimmel Medical College Philadelphia Pennsylvania USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2328

Reference10 articles.

1. Recommendations for patient similarity classes: results of the AMIA 2019 workshop on defining patient similarity

2. Integrating pharmacogenomics into electronic health records with clinical decision support

3. Electronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts

4. Office of the National Coordinator for Health Information Technology.HealthIT.gov. Connecting Health and Care for the Nation: A 10‐Year Vision to Achieve an Interoperable Health IT Infrastructure. Accessed May 20 2021.

5. Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating pharmacogenomic testing into paired germline and somatic genomic testing in patients with cancer;Pharmacogenomics;2023-08

2. Comparison of variants in TPMT and NUDT15 between sequencing and genotyping methods in a multistate pediatric institution;Clinical and Translational Science;2023-07-06

3. How to implement a pharmacogenetics service at your institution;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2022-09-12

4. The Value of Pharmacogenetics to Reduce Drug-Related Toxicity in Cancer Patients;Molecular Diagnosis & Therapy;2022-02-03

5. Realities of Pharmacogenomic and Minimizing Misconceptions and Medication Misadventures;Delaware Journal of Public Health;2021-12